The Asbestos Diseases Research Institute Biobank

Certification Status: Invite Member
Registration Status: Completed

The ADRI Biobank is the biorepository of the Asbestos Diseases Research Institute, a not-for-profit organisation with the mission to investigate the epidemiology of asbestos related lung diseases and to improve the diagnostic and preventative measure in these diseases. The overall aim of the ADRI Biobank is to provide approved investigators and collaborators with high quality biospecimens and data in order to improve the diagnosis and treatment of asbestos-related diseases and to contribute to effective preventive measures.

Registered Biobank Name The Asbestos Diseases Research Institute Biobank
Biobank Leader Kan Chen
Principal Investigator Professor Nico van Zandwijk
Address Bernie Banton Centre, Gate 3 Hospital Road
Concord, NSW, Australia
Email for biobank inquiries
User Type
  • Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
  • Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
  • Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper
Poly - Collection aimed at supporting undetermined, multiple users with ethics approved research projects, through a defined access/application mechanism.
Biospecimen Collected: